Our unswerving focus on innovation and market-based research has resulted in an unrivalled track record of industry “firsts”. These include being the first biotech company to apply protein engineering to improve manufacturing outcomes, and the first to develop and deliver commercially viable microbial expression systems for enzymes.
In May 2011, DuPont acquired a majority stake in Danisco A/S, including its Genencor division. Genencor and the DuPont Danisco Cellulosic Ethanol joint venture are now fully integrated within the DuPont Industrial Biosciences business unit.
This acquisition advances DuPont's global efforts to provide sustainable solutions to a growing global population, particularly in the areas of food, bioenergy, and biomaterials.
Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in approximately 90 countries, DuPont offers a wide range of innovative products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation and apparel. Read more at DuPont.com
1982 Genentech and Corning Glassworks form Genencor Inc.
1990 First to express mammalian gene in Fungi
1995 Acquires Gist Brocades Enzymes N.V.
1995 Acquires enzymes division of Solvay
2000 Launch of the first product commercialized via Directed Evolution
2002 Acquires Enzyme Biosystems & Rhodia Feed & Brewing
2003 Acquires manufacturing facility in Wuxi, China 1995
2005 Danisco A/S acquires Genencor
2007 The first to deliver a commercially viable enzyme for cellulosic ethanol
2008 Launches DDCE Joint Venture with Dupont to develop cellulosic ethanol
2008 Launch of BioIsoprene™ monomer, the first renewable biobased alternative to isoprene for synthetic rubber production
2009 The first to bring bio-based bleaching alternatives to textile processing
2011 DuPont acquires Danisco A/S, including its Genencor division